Effects on type 2 immunity when specifically targeting the interleukin-13 cytokine with tralokinumab

被引:0
|
作者
Guttman-Yassky, Emma [1 ,2 ]
Kabashima, Kenji [3 ]
Pavel, Ana [4 ]
Staumont-Salle, Delphine [5 ]
Jiang, Li [6 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY USA
[3] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan
[4] Icahn Sch Med Mt Sinai, Dept Dermatol, Lab Inflammatory Skin Dis, New York, NY USA
[5] Univ Lille, Univ Hosp Lille, Dept Dermatol, Lille, France
[6] LEO Pharma AS, Madison, NJ USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
25854
引用
收藏
页码:AB72 / AB72
页数:1
相关论文
共 50 条
  • [31] Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers
    Liang, Ruijia
    Wu, Cheng
    Liu, Shiming
    Zhao, Wenyan
    DRUG DELIVERY, 2022, 29 (01) : 1620 - 1630
  • [32] Therapeutic Targeting of the Interleukin-4/Interleukin-13 Signaling Pathway: In Allergy and Beyond
    Danielle Karo-Atar
    Almog Bitton
    Itai Benhar
    Ariel Munitz
    BioDrugs, 2018, 32 : 201 - 220
  • [33] EFFECTS OF INTERLEUKIN-4 ON MONOCYTE FUNCTIONS - COMPARISON TO INTERLEUKIN-13
    MALEFYT, RD
    FIGDOR, CG
    DEVRIES, JE
    RESEARCH IN IMMUNOLOGY, 1993, 144 (08): : 629 - 633
  • [34] The contribution of interleukin-13 and -15 to the cytokine network within normal and diseased gingiva
    Johnson, Roger B.
    Serio, Francis G.
    JOURNAL OF PERIODONTOLOGY, 2007, 78 (04) : 691 - 695
  • [35] Comparative studies on the effects of interleukin-4 and interleukin-13 on cytokine and prostaglandin E2 production by amnion-derived WISH cells
    Keelan, JA
    Sato, TA
    Mitchell, MD
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 40 (05): : 332 - 338
  • [36] INTERLEUKIN-13 AS AN IMPORTANT CYTOKINE: A REVIEW ON ITS ROLES IN SOME HUMAN DISEASES
    Seyfizadeh, Narges
    Seyfizadeh, Nayer
    Gharibi, Tohid
    Babaloo, Zohreh
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2015, 62 (04) : 341 - 378
  • [37] The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps
    Bachert, Claus
    Hicks, Alexandra
    Gane, Simon
    Peters, Anju T.
    Gevaert, Philippe
    Nash, Scott
    Horowitz, Julie E.
    Sacks, Harry
    Jacob-Nara, Juby A.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] Safety of specifically targeting interleukin-13 with tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase III and phase II trials
    Simpson, E.
    Merola, J. F.
    Silverberg, J. I.
    Zachariae, R.
    Olsen, C. K.
    Wollenberg, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E66 - E66
  • [39] Interleukin-13 is a novel Th2 cytokine with anti-inflammatory activities: Comparison to interleukin-4 and interleukin-10
    Malefyt, RD
    Figdor, CG
    Zurawski, G
    deVries, JE
    IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS - MECHANISMS AND THERAPEUTIC APPROACHES, VOL I: MOF, MODS AND SIRS - BASIC MECHANISMS IN INFLAMMATION AND TISSUE INJURY, 1996, : 308 - 314
  • [40] Interleukin-4 and interleukin-13: Bidirectional effects on human osteoclast formation
    Scopes, J
    Massey, HM
    Ebrahim, H
    Horton, MA
    Flanagan, AM
    BONE, 2001, 29 (03) : 203 - 208